Search company, investor...

Avidex

Stage

Acquired | Acquired

About Avidex

Avidex is a spin out from Oxford University. The company is developing T-Cell receptors for use in stem cell research focused on cures for various diseases including cancers, osteoporosis, and multiple sclerosis.

Headquarters Location

Oxford, England,

United Kingdom

Missing: Avidex's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Avidex's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Avidex

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Avidex is included in 1 Expert Collection, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Latest Avidex News

Listen Technologies Partners with Avidex for Distribution in Greece

Oct 12, 2020

Listen Technologies Partners with Avidex for Distribution in Greece Listen Technologies  Corporation, a provider of advanced wireless listening solutions for 22 years, announced that it has partnered with Avidex , an audiovisual (AV) distributor and integrator based in Athens, Greece. Avidex will distribute Listen Technologies’ communications systems to businesses and venues throughout Greece. Avidex has more than 20 years of experience addressing the AV needs of end users and businesses across several markets. Its clients include private corporations, education and cultural foundations, and commercial facilities. “Avidex shares Listen Technologies’ passion for delivering outstanding customer service and meeting the unique needs of each client,” said  Flemming Bjerke , vice president of business development and managing director of Listen Europe, Listen Technologies. “We are excited to partner with Avidex to bring clear audio solutions to market in Greece, especially as businesses and venues adapt to physical distancing and mask requirements intended to promote safety.”  Requiring employees and guests to maintain physical distance and wear face coverings are ways to mitigate the spread of COVID-19, but these measures can create barriers to communication, safety, and even productivity. Listen Technologies’ wireless audio solutions help businesses and venues overcome the challenges of distance, masks, background noise, and hearing loss so people can hear clearly and engage. ListenTALK  is a mobile two-way communication system that enables group communication with the touch of a button. Users “can hear others clearly up to 200 meters away, without shouting, even while wearing masks.” The units are “easy to clean and disinfect and are ideal for manufacturing and office environments,” according to the company. Listen EVERYWHERE  streams audio over Wi-Fi to personal smartphones and Bluetooth-enabled hearing aids. Applications include drive-in movies, graduations, and worship services. ListenIR  uses infrared (IR) technology to transmit and receive audio where audio needs to be private, including in courtrooms, boardrooms, and adjacent classrooms. “We are pleased to cooperate with Listen Technologies and distribute their products in Greece,” said Fenia Karkantzou, marketing coordinator, Avidex. “Listen Technologies’ product portfolio offers clear and smart system solutions to group communication issues. We firmly believe that this partnership will have a positive impact in the Greek market, and despite the pandemic, Listen Technologies products will find their expected response.”  Source: Listen Technologies

Avidex Frequently Asked Questions (FAQ)

  • Where is Avidex's headquarters?

    Avidex's headquarters is located at Oxford.

  • What is Avidex's latest funding round?

    Avidex's latest funding round is Acquired.

  • Who are the investors of Avidex?

    Investors of Avidex include MediGene, University of Oxford and Advent Venture Partners.

  • Who are Avidex's competitors?

    Competitors of Avidex include Esperance Pharmaceuticals, Endocare, OncoMed Pharmaceuticals, CoImmune, TxCell and 13 more.

Compare Avidex to Competitors

E
Esperance Pharmaceuticals

Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.

B
BresaGen

NovoCell, Inc./BresaGen is a stem cell engineering company dedicated to creating, delivering, and commercializing cell and drug therapies to treat diabetes and other chronic diseases. Novocell uses its cell encapsulation technology and expertise in cell implantation to develop a renewable source of specialized cells for the treatment of cellular diseases. Bresagen represents a division of Novocell's research operation.

ReproCELL Logo
ReproCELL

ReproCell is a developer of stem cell technologies. The company develops various products, with an underlying theme that focuses on stem cell technology, to address the needs of researchers and clinicians. The product range encompasses reagents for ES/iPS cells and stem cell-derived functional cells.

Regenetech Logo
Regenetech

Regenetech develops and offers intellectual property licenses in the area of Adult Stem Cell Expansion and therapeutic applications of adult stem cells. Regenetech uses a technology discovered by NASA in space experiments for growing three-dimensional (3D) stem cells in a weightless environment.

I
Intarcia Therapeutics

Intarcia Therapeutics is a biopharmaceutical company based in Boston, Massachusetts. Intarcia is engaged in the development of a pipeline of products for the proprietary Medici Drug Delivery System comprised of three technologies: A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, a matchstick-sized osmotic mini-pump that is placed under the dermal layer of skin to deliver a continuous and consistent flow of medication, and a placement technology including proprietary tools designed to provide an optimal user experience.

C
Chimeric Therapies

Developer of bone marrow graft engineering to expand the use of safe and effective cellular grafts tailored to treat and cure diseases of the immune system and blood system.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.